Innovating & improved solutions in infectious diseases
From microbe to One Health
Our fields
Human Health
Tacle infectious
diseases
Animal Health
Reduce use
of antibiotics
Microbes &
Environment
Control microbes
proliferation /
dissemination
Nutraceuticals
Role of gut
microbiota
About
Vibiosphen
One Health paradigm promotes a global effort to achieve the best solutions for human and animal health considering the environment.
Relevant expertise and services
Our partners
Latest news about Vibiosphen
Microbiome Movement Drug Development Europe
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Microbiome Movement Drug Development Europe
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Human - Animal One Health: At the Confluence of human & veterinary public health
Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both